1. Home
  2. UNCY vs SOTK Comparison

UNCY vs SOTK Comparison

Compare UNCY & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • SOTK
  • Stock Information
  • Founded
  • UNCY 2016
  • SOTK 1975
  • Country
  • UNCY United States
  • SOTK United States
  • Employees
  • UNCY N/A
  • SOTK N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • SOTK Industrial Machinery/Components
  • Sector
  • UNCY Health Care
  • SOTK Technology
  • Exchange
  • UNCY Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • UNCY 91.0M
  • SOTK 58.5M
  • IPO Year
  • UNCY 2021
  • SOTK 1987
  • Fundamental
  • Price
  • UNCY $4.88
  • SOTK $3.68
  • Analyst Decision
  • UNCY Strong Buy
  • SOTK Hold
  • Analyst Count
  • UNCY 4
  • SOTK 1
  • Target Price
  • UNCY $63.75
  • SOTK N/A
  • AVG Volume (30 Days)
  • UNCY 1.2M
  • SOTK 5.4K
  • Earning Date
  • UNCY 08-13-2025
  • SOTK 07-10-2025
  • Dividend Yield
  • UNCY N/A
  • SOTK N/A
  • EPS Growth
  • UNCY N/A
  • SOTK N/A
  • EPS
  • UNCY N/A
  • SOTK 0.09
  • Revenue
  • UNCY N/A
  • SOTK $20,606,116.00
  • Revenue This Year
  • UNCY N/A
  • SOTK N/A
  • Revenue Next Year
  • UNCY $1,458.53
  • SOTK $9.53
  • P/E Ratio
  • UNCY N/A
  • SOTK $40.34
  • Revenue Growth
  • UNCY N/A
  • SOTK N/A
  • 52 Week Low
  • UNCY $2.02
  • SOTK $3.50
  • 52 Week High
  • UNCY $11.00
  • SOTK $6.05
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 43.02
  • SOTK 50.01
  • Support Level
  • UNCY $4.31
  • SOTK $3.63
  • Resistance Level
  • UNCY $5.55
  • SOTK $3.78
  • Average True Range (ATR)
  • UNCY 0.76
  • SOTK 0.13
  • MACD
  • UNCY -0.10
  • SOTK 0.00
  • Stochastic Oscillator
  • UNCY 16.26
  • SOTK 52.38

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: